drug protocol number

2241130

drug sponsor

Astrazeneca

drug study

Anifrolumab

drug trial site

Aseer Central Hospital (Abha), International Medical Center (Jeddah), King Khalid University Hospital (Riyadh)

drug status

Ongoing

drug phase